A retrospective analysis of treatment responses of palmoplantar psoriasis in 114 patients

Background  Treatment options remain unsatisfactory for patients with palmoplantar psoriasis (PP) and palmoplantar pustular psoriasis (PPP). Aim  To evaluate the therapeutic responses of PP and PPP patients that were treated in our psoriasis polyclinic between 2003 and 2007. Methods  This retrospect...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the European Academy of Dermatology and Venereology 2009-07, Vol.23 (7), p.814-819
Hauptverfasser: Adışen, E, Tekin, O, Gülekon, A, Gürer, MA
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 819
container_issue 7
container_start_page 814
container_title Journal of the European Academy of Dermatology and Venereology
container_volume 23
creator Adışen, E
Tekin, O
Gülekon, A
Gürer, MA
description Background  Treatment options remain unsatisfactory for patients with palmoplantar psoriasis (PP) and palmoplantar pustular psoriasis (PPP). Aim  To evaluate the therapeutic responses of PP and PPP patients that were treated in our psoriasis polyclinic between 2003 and 2007. Methods  This retrospective study comprised PP (n = 62) and PPP (n = 52) patients. Treatments were individualized according to patient compliance and associating systemic diseases. The effect of systemic treatments was grouped as follows: ‘no improvement’: patients unresponsive for the present treatment; ‘partial improvement’:  75% decrease of the disease compared to baseline. Results  In the PP group, 17 of 62 patients showed marked improvement to topical agents, while the remaining patients required systemic agents including oral retinoids (n = 24), local psoralen plus ultraviolet A (PUVA; n = 12), methotrexate (n = 9) and cyclosporine (n = 2). Marked improvement was achieved in 53%, 45%, 47% and 100%, respectively. In these patients, two (n = 10), three (n = 5), or four (n = 5) systemic agents were used alternately. In the PPP group, 18 of 52 patients achieved marked improvement by topical agents. Patients that required systemic agents were treated with colchicum (n = 19), local PUVA (n = 8), methotrexate (n = 4), oral retinoids (n = 3) and cyclosporine (n = 2). These treatments achieved a marked improvement in 60%, 33%, 57%, 83%, and 50% of the patients, respectively. In the course of the disease, 18 patients required two and 3 patients required three systemic agents alternately. Conclusions  Although the success rates appeared to be high, the high number of patients who required multiple systemic agents emphasized the fact that localized forms of psoriasis were resistant to therapy. Conflicts of interest None declared
doi_str_mv 10.1111/j.1468-3083.2009.03197.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67547183</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20069172</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5027-191d0e595aa9273458976db3e9c97480f87e1d90546a1e3349dfdbc201b3e9923</originalsourceid><addsrcrecordid>eNqNkE1v1DAQhi0EokvhL6CcuCX1xHGcOXCottBSraBCfAguljeZSF7yVdvb7v57nO6qHKkvtjzvM2M_jCXAM4jrbJNBUVap4JXIcs4x4wJQZbtnbPFYeM4WHPMyRZR4wl55v-GcA8jqJTsBLBTnpViwX-eJo-BGP1Ed7B0lZjDd3lufjG0SHJnQ0xBixk_j4OnhejJdP06dGYJxyeRHZ80M2CEBKGI12Ij41-xFazpPb477Kfv-8cO35VW6-nL5aXm-SmvJc5UCQsNJojQGcyUKWaEqm7UgrFEVFW8rRdAgl0VpgIQosGmbdZ1zmDOYi1P27tB3cuPtlnzQvfU1dfF9NG69LpUsFFTiv8EoskRQc8fqEKyjF--o1ZOzvXF7DVzP_vVGz5r1rHnGUD_417uIvj3O2K57av6BR-Ex8P4QuLcd7Z_cWF9f_JhPkU8PvPWBdo-8cX_iR4WS-ufnS728XqrfX1cX-kb8BcrVov0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20069172</pqid></control><display><type>article</type><title>A retrospective analysis of treatment responses of palmoplantar psoriasis in 114 patients</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Adışen, E ; Tekin, O ; Gülekon, A ; Gürer, MA</creator><creatorcontrib>Adışen, E ; Tekin, O ; Gülekon, A ; Gürer, MA</creatorcontrib><description>Background  Treatment options remain unsatisfactory for patients with palmoplantar psoriasis (PP) and palmoplantar pustular psoriasis (PPP). Aim  To evaluate the therapeutic responses of PP and PPP patients that were treated in our psoriasis polyclinic between 2003 and 2007. Methods  This retrospective study comprised PP (n = 62) and PPP (n = 52) patients. Treatments were individualized according to patient compliance and associating systemic diseases. The effect of systemic treatments was grouped as follows: ‘no improvement’: patients unresponsive for the present treatment; ‘partial improvement’: &lt; 50% decrease in severity or affected area; ‘moderate improvement’: 50–75% decrease in severity or affected area, and ‘marked improvement’: &gt; 75% decrease of the disease compared to baseline. Results  In the PP group, 17 of 62 patients showed marked improvement to topical agents, while the remaining patients required systemic agents including oral retinoids (n = 24), local psoralen plus ultraviolet A (PUVA; n = 12), methotrexate (n = 9) and cyclosporine (n = 2). Marked improvement was achieved in 53%, 45%, 47% and 100%, respectively. In these patients, two (n = 10), three (n = 5), or four (n = 5) systemic agents were used alternately. In the PPP group, 18 of 52 patients achieved marked improvement by topical agents. Patients that required systemic agents were treated with colchicum (n = 19), local PUVA (n = 8), methotrexate (n = 4), oral retinoids (n = 3) and cyclosporine (n = 2). These treatments achieved a marked improvement in 60%, 33%, 57%, 83%, and 50% of the patients, respectively. In the course of the disease, 18 patients required two and 3 patients required three systemic agents alternately. Conclusions  Although the success rates appeared to be high, the high number of patients who required multiple systemic agents emphasized the fact that localized forms of psoriasis were resistant to therapy. Conflicts of interest None declared</description><identifier>ISSN: 0926-9959</identifier><identifier>EISSN: 1468-3083</identifier><identifier>DOI: 10.1111/j.1468-3083.2009.03197.x</identifier><identifier>PMID: 19470063</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adolescent ; Adult ; Aged ; Child ; Colchicum ; Cyclosporine - therapeutic use ; cyclosporine and retinoids ; Female ; Humans ; Keratoderma, Palmoplantar - drug therapy ; Male ; methotrexate ; Methotrexate - therapeutic use ; Middle Aged ; palmoplantar psoriasis ; palmoplantar pustular psoriasis ; Photochemotherapy ; Psoriasis - drug therapy ; PUVA ; Retinoids - therapeutic use ; Retrospective Studies ; systemic treatment ; topical corticosteroids ; Treatment Outcome ; Young Adult</subject><ispartof>Journal of the European Academy of Dermatology and Venereology, 2009-07, Vol.23 (7), p.814-819</ispartof><rights>2009 The Authors. Journal compilation © 2009 European Academy of Dermatology and Venereology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5027-191d0e595aa9273458976db3e9c97480f87e1d90546a1e3349dfdbc201b3e9923</citedby><cites>FETCH-LOGICAL-c5027-191d0e595aa9273458976db3e9c97480f87e1d90546a1e3349dfdbc201b3e9923</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1468-3083.2009.03197.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1468-3083.2009.03197.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,782,786,1419,27931,27932,45581,45582</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19470063$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Adışen, E</creatorcontrib><creatorcontrib>Tekin, O</creatorcontrib><creatorcontrib>Gülekon, A</creatorcontrib><creatorcontrib>Gürer, MA</creatorcontrib><title>A retrospective analysis of treatment responses of palmoplantar psoriasis in 114 patients</title><title>Journal of the European Academy of Dermatology and Venereology</title><addtitle>J Eur Acad Dermatol Venereol</addtitle><description>Background  Treatment options remain unsatisfactory for patients with palmoplantar psoriasis (PP) and palmoplantar pustular psoriasis (PPP). Aim  To evaluate the therapeutic responses of PP and PPP patients that were treated in our psoriasis polyclinic between 2003 and 2007. Methods  This retrospective study comprised PP (n = 62) and PPP (n = 52) patients. Treatments were individualized according to patient compliance and associating systemic diseases. The effect of systemic treatments was grouped as follows: ‘no improvement’: patients unresponsive for the present treatment; ‘partial improvement’: &lt; 50% decrease in severity or affected area; ‘moderate improvement’: 50–75% decrease in severity or affected area, and ‘marked improvement’: &gt; 75% decrease of the disease compared to baseline. Results  In the PP group, 17 of 62 patients showed marked improvement to topical agents, while the remaining patients required systemic agents including oral retinoids (n = 24), local psoralen plus ultraviolet A (PUVA; n = 12), methotrexate (n = 9) and cyclosporine (n = 2). Marked improvement was achieved in 53%, 45%, 47% and 100%, respectively. In these patients, two (n = 10), three (n = 5), or four (n = 5) systemic agents were used alternately. In the PPP group, 18 of 52 patients achieved marked improvement by topical agents. Patients that required systemic agents were treated with colchicum (n = 19), local PUVA (n = 8), methotrexate (n = 4), oral retinoids (n = 3) and cyclosporine (n = 2). These treatments achieved a marked improvement in 60%, 33%, 57%, 83%, and 50% of the patients, respectively. In the course of the disease, 18 patients required two and 3 patients required three systemic agents alternately. Conclusions  Although the success rates appeared to be high, the high number of patients who required multiple systemic agents emphasized the fact that localized forms of psoriasis were resistant to therapy. Conflicts of interest None declared</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Child</subject><subject>Colchicum</subject><subject>Cyclosporine - therapeutic use</subject><subject>cyclosporine and retinoids</subject><subject>Female</subject><subject>Humans</subject><subject>Keratoderma, Palmoplantar - drug therapy</subject><subject>Male</subject><subject>methotrexate</subject><subject>Methotrexate - therapeutic use</subject><subject>Middle Aged</subject><subject>palmoplantar psoriasis</subject><subject>palmoplantar pustular psoriasis</subject><subject>Photochemotherapy</subject><subject>Psoriasis - drug therapy</subject><subject>PUVA</subject><subject>Retinoids - therapeutic use</subject><subject>Retrospective Studies</subject><subject>systemic treatment</subject><subject>topical corticosteroids</subject><subject>Treatment Outcome</subject><subject>Young Adult</subject><issn>0926-9959</issn><issn>1468-3083</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkE1v1DAQhi0EokvhL6CcuCX1xHGcOXCottBSraBCfAguljeZSF7yVdvb7v57nO6qHKkvtjzvM2M_jCXAM4jrbJNBUVap4JXIcs4x4wJQZbtnbPFYeM4WHPMyRZR4wl55v-GcA8jqJTsBLBTnpViwX-eJo-BGP1Ed7B0lZjDd3lufjG0SHJnQ0xBixk_j4OnhejJdP06dGYJxyeRHZ80M2CEBKGI12Ij41-xFazpPb477Kfv-8cO35VW6-nL5aXm-SmvJc5UCQsNJojQGcyUKWaEqm7UgrFEVFW8rRdAgl0VpgIQosGmbdZ1zmDOYi1P27tB3cuPtlnzQvfU1dfF9NG69LpUsFFTiv8EoskRQc8fqEKyjF--o1ZOzvXF7DVzP_vVGz5r1rHnGUD_417uIvj3O2K57av6BR-Ex8P4QuLcd7Z_cWF9f_JhPkU8PvPWBdo-8cX_iR4WS-ufnS728XqrfX1cX-kb8BcrVov0</recordid><startdate>200907</startdate><enddate>200907</enddate><creator>Adışen, E</creator><creator>Tekin, O</creator><creator>Gülekon, A</creator><creator>Gürer, MA</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>200907</creationdate><title>A retrospective analysis of treatment responses of palmoplantar psoriasis in 114 patients</title><author>Adışen, E ; Tekin, O ; Gülekon, A ; Gürer, MA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5027-191d0e595aa9273458976db3e9c97480f87e1d90546a1e3349dfdbc201b3e9923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Child</topic><topic>Colchicum</topic><topic>Cyclosporine - therapeutic use</topic><topic>cyclosporine and retinoids</topic><topic>Female</topic><topic>Humans</topic><topic>Keratoderma, Palmoplantar - drug therapy</topic><topic>Male</topic><topic>methotrexate</topic><topic>Methotrexate - therapeutic use</topic><topic>Middle Aged</topic><topic>palmoplantar psoriasis</topic><topic>palmoplantar pustular psoriasis</topic><topic>Photochemotherapy</topic><topic>Psoriasis - drug therapy</topic><topic>PUVA</topic><topic>Retinoids - therapeutic use</topic><topic>Retrospective Studies</topic><topic>systemic treatment</topic><topic>topical corticosteroids</topic><topic>Treatment Outcome</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Adışen, E</creatorcontrib><creatorcontrib>Tekin, O</creatorcontrib><creatorcontrib>Gülekon, A</creatorcontrib><creatorcontrib>Gürer, MA</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the European Academy of Dermatology and Venereology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Adışen, E</au><au>Tekin, O</au><au>Gülekon, A</au><au>Gürer, MA</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A retrospective analysis of treatment responses of palmoplantar psoriasis in 114 patients</atitle><jtitle>Journal of the European Academy of Dermatology and Venereology</jtitle><addtitle>J Eur Acad Dermatol Venereol</addtitle><date>2009-07</date><risdate>2009</risdate><volume>23</volume><issue>7</issue><spage>814</spage><epage>819</epage><pages>814-819</pages><issn>0926-9959</issn><eissn>1468-3083</eissn><abstract>Background  Treatment options remain unsatisfactory for patients with palmoplantar psoriasis (PP) and palmoplantar pustular psoriasis (PPP). Aim  To evaluate the therapeutic responses of PP and PPP patients that were treated in our psoriasis polyclinic between 2003 and 2007. Methods  This retrospective study comprised PP (n = 62) and PPP (n = 52) patients. Treatments were individualized according to patient compliance and associating systemic diseases. The effect of systemic treatments was grouped as follows: ‘no improvement’: patients unresponsive for the present treatment; ‘partial improvement’: &lt; 50% decrease in severity or affected area; ‘moderate improvement’: 50–75% decrease in severity or affected area, and ‘marked improvement’: &gt; 75% decrease of the disease compared to baseline. Results  In the PP group, 17 of 62 patients showed marked improvement to topical agents, while the remaining patients required systemic agents including oral retinoids (n = 24), local psoralen plus ultraviolet A (PUVA; n = 12), methotrexate (n = 9) and cyclosporine (n = 2). Marked improvement was achieved in 53%, 45%, 47% and 100%, respectively. In these patients, two (n = 10), three (n = 5), or four (n = 5) systemic agents were used alternately. In the PPP group, 18 of 52 patients achieved marked improvement by topical agents. Patients that required systemic agents were treated with colchicum (n = 19), local PUVA (n = 8), methotrexate (n = 4), oral retinoids (n = 3) and cyclosporine (n = 2). These treatments achieved a marked improvement in 60%, 33%, 57%, 83%, and 50% of the patients, respectively. In the course of the disease, 18 patients required two and 3 patients required three systemic agents alternately. Conclusions  Although the success rates appeared to be high, the high number of patients who required multiple systemic agents emphasized the fact that localized forms of psoriasis were resistant to therapy. Conflicts of interest None declared</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>19470063</pmid><doi>10.1111/j.1468-3083.2009.03197.x</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0926-9959
ispartof Journal of the European Academy of Dermatology and Venereology, 2009-07, Vol.23 (7), p.814-819
issn 0926-9959
1468-3083
language eng
recordid cdi_proquest_miscellaneous_67547183
source MEDLINE; Access via Wiley Online Library
subjects Adolescent
Adult
Aged
Child
Colchicum
Cyclosporine - therapeutic use
cyclosporine and retinoids
Female
Humans
Keratoderma, Palmoplantar - drug therapy
Male
methotrexate
Methotrexate - therapeutic use
Middle Aged
palmoplantar psoriasis
palmoplantar pustular psoriasis
Photochemotherapy
Psoriasis - drug therapy
PUVA
Retinoids - therapeutic use
Retrospective Studies
systemic treatment
topical corticosteroids
Treatment Outcome
Young Adult
title A retrospective analysis of treatment responses of palmoplantar psoriasis in 114 patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-06T01%3A54%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20retrospective%20analysis%20of%20treatment%20responses%20of%20palmoplantar%20psoriasis%20in%20114%20patients&rft.jtitle=Journal%20of%20the%20European%20Academy%20of%20Dermatology%20and%20Venereology&rft.au=Ad%C4%B1%C5%9Fen,%20E&rft.date=2009-07&rft.volume=23&rft.issue=7&rft.spage=814&rft.epage=819&rft.pages=814-819&rft.issn=0926-9959&rft.eissn=1468-3083&rft_id=info:doi/10.1111/j.1468-3083.2009.03197.x&rft_dat=%3Cproquest_cross%3E20069172%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20069172&rft_id=info:pmid/19470063&rfr_iscdi=true